Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.
WASHINGTON — Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.
In a press release, the company said its request for approval for all adults was made “to provide flexibility” to the Centers for Disease Control and Prevention and medical providers to determine the “appropriate use” of a second booster dose of the mRNA vaccine, “including for those at higher risk of COVID-19 due to age or comorbidities."
U.S. health officials currently recommend a primary series of two doses of the Moderna vaccine and a booster dose months later.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Three Covid-related deaths and 2,054 casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,266.
Read more »
Moderna Asks FDA to Clear Second Covid-19 Booster DoseThe company requested authorization of the extra shot for any adult who got a first booster dose.
Read more »
Moderna asks FDA to add 4th COVID-19 vaccine booster dose for all adults to EUADrugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.
Read more »
Moderna requests EUA for a second COVID-19 boosterModerna asked the Food and Drug Administration for emergency authorization of a second booster of its COVID-19 vaccine for all adults.
Read more »
Moderna seeks FDA authorization for second Covid-19 booster shot for all adultsModerna announced Thursday that it's asked the US Food and Drug Administration for authorization for a second Covid-19 booster shot for everyone 18 and older.
Read more »
Moderna asks FDA to approve second COVID-19 booster for adultsThe request was described as much broader than that of Pfizer and BioNTech which was filed with the FDA earlier in the week.
Read more »